List of Tables
Table 1. Global Rhabdomyosarcoma Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Rhabdomyosarcoma Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Rhabdomyosarcoma Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Rhabdomyosarcoma Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Rhabdomyosarcoma Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Rhabdomyosarcoma Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Rhabdomyosarcoma Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Rhabdomyosarcoma Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Rhabdomyosarcoma Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rhabdomyosarcoma Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rhabdomyosarcoma Drug, Product Type & Application
Table 12. Global Key Manufacturers of Rhabdomyosarcoma Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rhabdomyosarcoma Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rhabdomyosarcoma Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rhabdomyosarcoma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Rhabdomyosarcoma Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Rhabdomyosarcoma Drug Sales Market Share by Region (2020-2025)
Table 19. Global Rhabdomyosarcoma Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Rhabdomyosarcoma Drug Sales Market Share by Region (2026-2031)
Table 21. Global Rhabdomyosarcoma Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Rhabdomyosarcoma Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Rhabdomyosarcoma Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Rhabdomyosarcoma Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Rhabdomyosarcoma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Rhabdomyosarcoma Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Rhabdomyosarcoma Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Rhabdomyosarcoma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Rhabdomyosarcoma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Rhabdomyosarcoma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Rhabdomyosarcoma Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Rhabdomyosarcoma Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Rhabdomyosarcoma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Rhabdomyosarcoma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Rhabdomyosarcoma Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Rhabdomyosarcoma Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Rhabdomyosarcoma Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Rhabdomyosarcoma Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Rhabdomyosarcoma Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Rhabdomyosarcoma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Rhabdomyosarcoma Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Rhabdomyosarcoma Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Rhabdomyosarcoma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rhabdomyosarcoma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Rhabdomyosarcoma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Rhabdomyosarcoma Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Rhabdomyosarcoma Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Rhabdomyosarcoma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Rhabdomyosarcoma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Rhabdomyosarcoma Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Rhabdomyosarcoma Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Rhabdomyosarcoma Drug Sales Market Share by Type (2020-2025)
Table 53. Global Rhabdomyosarcoma Drug Sales Market Share by Type (2026-2031)
Table 54. Global Rhabdomyosarcoma Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Rhabdomyosarcoma Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Rhabdomyosarcoma Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Rhabdomyosarcoma Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Rhabdomyosarcoma Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Rhabdomyosarcoma Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Rhabdomyosarcoma Drug Sales Market Share by Application (2020-2025)
Table 63. Global Rhabdomyosarcoma Drug Sales Market Share by Application (2026-2031)
Table 64. Global Rhabdomyosarcoma Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Rhabdomyosarcoma Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Rhabdomyosarcoma Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Rhabdomyosarcoma Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Bellicum Pharmaceuticals Inc Company Information
Table 71. Bellicum Pharmaceuticals Inc Description and Business Overview
Table 72. Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Product
Table 74. Bellicum Pharmaceuticals Inc Recent Developments/Updates
Table 75. Boehringer Ingelheim GmbH Company Information
Table 76. Boehringer Ingelheim GmbH Description and Business Overview
Table 77. Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Product
Table 79. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 80. Bristol-Myers Squibb Co Company Information
Table 81. Bristol-Myers Squibb Co Description and Business Overview
Table 82. Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Product
Table 84. Bristol-Myers Squibb Co Recent Developments/Updates
Table 85. Celgene Corp Company Information
Table 86. Celgene Corp Description and Business Overview
Table 87. Celgene Corp Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Celgene Corp Rhabdomyosarcoma Drug Product
Table 89. Celgene Corp Recent Developments/Updates
Table 90. Eisai Co Ltd Company Information
Table 91. Eisai Co Ltd Description and Business Overview
Table 92. Eisai Co Ltd Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Eisai Co Ltd Rhabdomyosarcoma Drug Product
Table 94. Eisai Co Ltd Recent Developments/Updates
Table 95. Epizyme Inc Company Information
Table 96. Epizyme Inc Description and Business Overview
Table 97. Epizyme Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Epizyme Inc Rhabdomyosarcoma Drug Product
Table 99. Epizyme Inc Recent Developments/Updates
Table 100. Exelixis Inc Company Information
Table 101. Exelixis Inc Description and Business Overview
Table 102. Exelixis Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Exelixis Inc Rhabdomyosarcoma Drug Product
Table 104. Exelixis Inc Recent Developments/Updates
Table 105. Iproteos SL Company Information
Table 106. Iproteos SL Description and Business Overview
Table 107. Iproteos SL Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Iproteos SL Rhabdomyosarcoma Drug Product
Table 109. Iproteos SL Recent Developments/Updates
Table 110. Ipsen SA Company Information
Table 111. Ipsen SA Description and Business Overview
Table 112. Ipsen SA Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Ipsen SA Rhabdomyosarcoma Drug Product
Table 114. Ipsen SA Recent Developments/Updates
Table 115. MacroGenics Inc Company Information
Table 116. MacroGenics Inc Description and Business Overview
Table 117. MacroGenics Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. MacroGenics Inc Rhabdomyosarcoma Drug Product
Table 119. MacroGenics Inc Recent Developments/Updates
Table 120. NantKwest Inc Company Information
Table 121. NantKwest Inc Description and Business Overview
Table 122. NantKwest Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. NantKwest Inc Rhabdomyosarcoma Drug Product
Table 124. NantKwest Inc Recent Developments/Updates
Table 125. Novartis AG Company Information
Table 126. Novartis AG Description and Business Overview
Table 127. Novartis AG Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Novartis AG Rhabdomyosarcoma Drug Product
Table 129. Novartis AG Recent Developments/Updates
Table 130. Noxxon Pharma AG Company Information
Table 131. Noxxon Pharma AG Description and Business Overview
Table 132. Noxxon Pharma AG Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Noxxon Pharma AG Rhabdomyosarcoma Drug Product
Table 134. Noxxon Pharma AG Recent Developments/Updates
Table 135. Pfizer Inc Company Information
Table 136. Pfizer Inc Description and Business Overview
Table 137. Pfizer Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Pfizer Inc Rhabdomyosarcoma Drug Product
Table 139. Pfizer Inc Recent Developments/Updates
Table 140. Taiho Pharmaceutical Co Ltd Company Information
Table 141. Taiho Pharmaceutical Co Ltd Description and Business Overview
Table 142. Taiho Pharmaceutical Co Ltd Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Taiho Pharmaceutical Co Ltd Rhabdomyosarcoma Drug Product
Table 144. Taiho Pharmaceutical Co Ltd Recent Developments/Updates
Table 145. Taiwan Liposome Company Ltd Company Information
Table 146. Taiwan Liposome Company Ltd Description and Business Overview
Table 147. Taiwan Liposome Company Ltd Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Taiwan Liposome Company Ltd Rhabdomyosarcoma Drug Product
Table 149. Taiwan Liposome Company Ltd Recent Developments/Updates
Table 150. Tarveda Therapeutics Inc Company Information
Table 151. Tarveda Therapeutics Inc Description and Business Overview
Table 152. Tarveda Therapeutics Inc Rhabdomyosarcoma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Tarveda Therapeutics Inc Rhabdomyosarcoma Drug Product
Table 154. Tarveda Therapeutics Inc Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Rhabdomyosarcoma Drug Distributors List
Table 158. Rhabdomyosarcoma Drug Customers List
Table 159. Rhabdomyosarcoma Drug Market Trends
Table 160. Rhabdomyosarcoma Drug Market Drivers
Table 161. Rhabdomyosarcoma Drug Market Challenges
Table 162. Rhabdomyosarcoma Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rhabdomyosarcoma Drug
Figure 2. Global Rhabdomyosarcoma Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rhabdomyosarcoma Drug Market Share by Type: 2024 & 2031
Figure 4. ARI-4175 Product Picture
Figure 5. Celyvir Product Picture
Figure 6. Crizotinib Product Picture
Figure 7. Enoblituzumab Product Picture
Figure 8. AT-69 Product Picture
Figure 9. Axitinib Product Picture
Figure 10. Others Product Picture
Figure 11. Global Rhabdomyosarcoma Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Rhabdomyosarcoma Drug Market Share by Application: 2024 & 2031
Figure 13. Research Center
Figure 14. Hospital
Figure 15. Clinic
Figure 16. Others
Figure 17. Global Rhabdomyosarcoma Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Rhabdomyosarcoma Drug Market Size (2020-2031) & (US$ Million)
Figure 19. Global Rhabdomyosarcoma Drug Sales (2020-2031) & (K Pcs)
Figure 20. Global Rhabdomyosarcoma Drug Average Price (USD/Pcs) & (2020-2031)
Figure 21. Rhabdomyosarcoma Drug Report Years Considered
Figure 22. Rhabdomyosarcoma Drug Sales Share by Manufacturers in 2024
Figure 23. Global Rhabdomyosarcoma Drug Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Rhabdomyosarcoma Drug Players: Market Share by Revenue in Rhabdomyosarcoma Drug in 2024
Figure 25. Rhabdomyosarcoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Rhabdomyosarcoma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Rhabdomyosarcoma Drug Sales Market Share by Country (2020-2031)
Figure 28. North America Rhabdomyosarcoma Drug Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Rhabdomyosarcoma Drug Sales Market Share by Country (2020-2031)
Figure 32. Europe Rhabdomyosarcoma Drug Revenue Market Share by Country (2020-2031)
Figure 33. Germany Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Rhabdomyosarcoma Drug Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Rhabdomyosarcoma Drug Revenue Market Share by Region (2020-2031)
Figure 40. China Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Taiwan Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Philippines Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Rhabdomyosarcoma Drug Sales Market Share by Country (2020-2031)
Figure 51. Latin America Rhabdomyosarcoma Drug Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Rhabdomyosarcoma Drug Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Rhabdomyosarcoma Drug Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Rhabdomyosarcoma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Rhabdomyosarcoma Drug by Type (2020-2031)
Figure 61. Global Revenue Market Share of Rhabdomyosarcoma Drug by Type (2020-2031)
Figure 62. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Type (2020-2031)
Figure 63. Global Sales Market Share of Rhabdomyosarcoma Drug by Application (2020-2031)
Figure 64. Global Revenue Market Share of Rhabdomyosarcoma Drug by Application (2020-2031)
Figure 65. Global Rhabdomyosarcoma Drug Price (USD/Pcs) by Application (2020-2031)
Figure 66. Rhabdomyosarcoma Drug Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
